These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 16391396

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-idiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use.
    Caccavo D, Vaccaro F, Ferri GM, Amoroso A, Bonomo L.
    J Autoimmun; 1994 Aug; 7(4):537-48. PubMed ID: 7980854
    [Abstract] [Full Text] [Related]

  • 6. Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.
    Zandman-Goddard G, Blank M, Shoenfeld Y.
    Lupus; 2009 Sep; 18(10):884-8. PubMed ID: 19671787
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade.
    Svetlicky N, Ortega-Hernandez OD, Mouthon L, Guillevin L, Thiesen HJ, Altman A, Kravitz MS, Blank M, Shoenfeld Y.
    J Clin Immunol; 2013 Jan; 33 Suppl 1():S27-32. PubMed ID: 23229779
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intravenous immunoglobulin therapy of antiphospholipid syndrome.
    Sherer Y, Levy Y, Shoenfeld Y.
    Rheumatology (Oxford); 2000 Apr; 39(4):421-6. PubMed ID: 10817776
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin.
    Sciascia S, Giachino O, Roccatello D.
    Clin Exp Rheumatol; 2012 Apr; 30(3):409-13. PubMed ID: 22513222
    [Abstract] [Full Text] [Related]

  • 15. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
    Jordan SC, Toyoda M.
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
    [Abstract] [Full Text] [Related]

  • 16. Antiphospholipid antibody levels in intravenous immunoglobulin (IVIg) preparations.
    Sherer Y, Wu R, Kraus I, Peter JB, Shoenfeld Y.
    Lupus; 2001 Jul; 10(8):568-70. PubMed ID: 11530999
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.
    Pierangeli SS, Espinola R, Liu X, Harris EN, Salmon JE.
    Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: immunological changes associated with a successful outcome.
    Arnout J, Spitz B, Wittevrongel C, Vanrusselt M, Van Assche A, Vermylen J.
    Thromb Haemost; 1994 Jun; 71(6):741-7. PubMed ID: 7974342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.